Rapid Access Beamtime for COVID-19 Research
Submitted by kperry on Wed, 02/19/2020 - 00:00
On February 18, 2020, in support of the COVID-19 outbreak, NE-CAT provided rapid access beamtime to researchers from the Walter Reed Army Institute of Research working on the the SARS-CoV-2 S glycoprotein receptor-binding-domain. The novel coronavirus's surface Spike (S) glycoprotein mediates cell entry via the human ACE-2 receptor, and is the principal target for the development of vaccines and immunotherapeutics.
Rapid Access Beamtime is available for all research projects related to COVID-19.